This inventor holds 2 USPTO granted patents. Top assignee: Augusta University Research Institute, Inc.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Mark Hamrick: Innovator in Pharmaceutical Compositions
Introduction
Mark Hamrick is an accomplished inventor based in Evans, Georgia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit IDO1. His work is crucial in addressing age-related muscle loss and related health issues.
Latest Patents
Mark Hamrick holds a patent for "Compositions and methods for inhibiting IDO1." This patent includes compounds that inhibit IDO1 and outlines methods of use for these compounds. Additionally, it provides pharmaceutical compositions and medicaments that incorporate these compounds, specifically targeting the treatment of sarcopenia or age-related muscle loss.
Career Highlights
Hamrick is affiliated with the Augusta University Research Institute, Inc., where he continues to advance his research and innovations. His work has the potential to impact the lives of many individuals suffering from muscle loss due to aging.
Collaborations
Mark collaborates with notable colleagues, including Carlos Isales and Iryna Lebedyeva. Their combined expertise enhances the research and development efforts at the institute.
Conclusion
Mark Hamrick is a notable inventor whose work in pharmaceutical compositions is paving the way for innovative treatments for age-related muscle loss. His contributions are vital to the ongoing research in this important area of health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile